VOR | Vor BiopharmaNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$19.86
+$0.61 (+3.17%)

Vor Biopharma (VOR) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2022.

The 50 SMA has sat above the 200 on the daily since Jul 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits between the 50 and the 200 on the daily, the weekly and the 4-hour.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
between the two $19.86 vs 50 $20.61 / 200 $17.38
Projection
No cross projected
Test
No active test
Last cross
Golden cross 22 Jul 2026 ยท projected 20 bars out

Weekly as of 30 Oct 16:00 ET

Price
between the two $19.68 vs 50 $16.27 / 200 $36.12
Projection
No cross projected
Test
No active test
Last cross
No cross on record

4-hour as of 3 Nov 16:00 ET

Price
between the two $19.86 vs 50 $19.08 / 200 $20.07
Projection
No cross projected
Test
No active test
Last cross
Death cross 20 Oct 2026 bar 1 ยท projected 30 bars out ยท tested 2 bars

Cross history

18
crosses on record since 2022
9 golden9 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
20 Oct 2026Death4-hour30 bars out2 bar cross test
22 Jul 2026Golden moderatedaily20 bars outNot tested
1 Jul 2026Golden4-hour30 bars outNot tested
15 Jun 2026Death4-hour14 bars out3 bar cross test
18 Mar 2026Golden4-hour26 bars outNot tested

About VOR

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$16.7M
4-hour coverageYes, since Oct 2025
History on recordSince 2022
SectorHealthcare
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.